Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients
Author:
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Clinical Neurology,Oncology
Link
http://academic.oup.com/neuro-oncology/article-pdf/17/6/784/6838617/nou322.pdf
Reference99 articles.
1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2. Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials
3. Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis
4. Antiangiogenic therapy for high-grade gliomas: current concepts and limitations
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment;Journal of Neuro-Oncology;2024-01
2. Insights into the Role of LncRNAs and miRNAs in Glioma Progression and Their Potential as Novel Therapeutic Targets;Cancers;2023-06-22
3. Neovascularization, vascular mimicry and molecular exchange: The imaging of tumorous tissue aggressiveness based on tissue perfusion;European Journal of Radiology;2023-06
4. In Vivo Quantitative Imaging of Glioma Heterogeneity Employing Positron Emission Tomography;Cancers;2022-06-27
5. 18F-FSPG PET/CT Imaging of System xC– Transporter Activity in Patients with Primary and Metastatic Brain Tumors;Radiology;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3